PCI The Journeys Within

Current Edition

Frankfurt 2027 – 12/10/26
ramusmedical
Regional News

Pfizer, ex-employee reach a deal in COVID-19 vaccine trade secrets case

A now-former Pfizer employee is playing nice after the drugmaker sued her in November alleging the 15-year veteran uploaded more than 12,000 sensitive files—including...
Continue Reading →
Regional News

Teligent, Edge Pharma yank meds on superpotency, sterility concerns

Sterility concerns and out-of-spec testing results are two common sources of drug recalls. Now, the problems have hit two drugmakers at once. For one of the companies...
Continue Reading →
Regional News

As end of New York opioid trial nears, AbbVie’s Allergan ponies up $200M to settle its part of the case

On the day of closing arguments in a high-profile New York opioid trial, AbbVie has inked a $200 million settlement to put the case to bed. AbbVie's Allergan has agr...
Continue Reading →
Regional News

Amid consumer spinoff and CEO transition, Johnson & Johnson names new leadership team

Less than a month after revealing a plan to spin its consumer health business off as a new publicly traded company, Johnson & Johnson has shed more light on its f...
Continue Reading →
Regional News

Amid Aduhelm’s rocky launch, Biogen eyes large-scale layoffs

Between slow sales, safety concerns and a likely European rejection, newly minted Alzheimer's disease drug Aduhelm has proven more of a headache than a blessing for d...
Continue Reading →
Regional News

Another Samsung Bioepis? Biocon, Viatris mull merging biosimilar businesses

Samsung Bioepis represents the marriage of an Asian company and a Western drugmaker with a focus on biosimilars. Now, two other players are reportedly considering a s...
Continue Reading →
Regional News

Klick Health spreads good cheer, and $100 bills, in annual holiday video highlighting the joy of giving

'Tis the season of giving. One Klick Health employee stuffed $20 bills into envelopes, wrote “Just Because” on the front and stuck them on the windshields of five ran...
Continue Reading →
Regional News

Novartis CEO Narashimhan confirms interest in purchase of generics unit Sandoz

Amid Novartis' strategic review of generics unit Sandoz, last month came word that Swedish investment group EQT and the Struengmann brothers of Germany were consideri...
Continue Reading →
Regional News

China’s new NRDL; Biocon-Viatris biosimilar merger?; Avistone’s $200M series A

China unveiled new inclusions in its national reimbursement drug list, featuring novel therapies from Biogen, Pfizer, Eli Lilly and more. Partners Biocon and Viatris ...
Continue Reading →
Regional News

GlaxoSmithKline vet departs for Vifor, the rumored target of a $7.1B CSL buyout

With a recent pruritus approval in the books and several more potential launches coming in the next year and a half, Switzerland’s Vifor Pharma is tapping longtime Gl...
Continue Reading →
Quotient